USANA Health Sciences, Inc. released its preliminary fiscal year 2025 net sales results. Net sales during the period are expected to reach approximately $925 million, beating its previously issued guidance of $920 million.
As the company looks to fiscal year 2026, net sales outlook is expected in the range of $925 million to $1 billion. Net sales outlook for 2026 includes $720 million to $765 million from USANA’s core nutritional business; $140 million to $155 million from Hiya; and $65 million to $80 million from Rise Wellness.
The company said Rise Wellness saw meaningful year-over-year net sales growth in 2025 and anticipates accelerated growth during fiscal 2026. With these results, operating margins are expected to be at breakeven in fiscal 2026 as the company invests strategically to drive future growth.
